The variation of CD4 +CD25 + regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODN

Targeted Oncology

Volumn 6, Issue 3, 2011, Pages 147-154

  Wang, Yan Ying ^a   He, Xiao Ye ^a   Cai, Ying Yun ^a   Wang, Zhi Jun ^a   Lu, Shao Hua ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Cytosine phosphorothioateguanine; Non small cell lung cancer; Oligodeoxyribonucleotide; Regulatory T cell; Tumor microenvironment

Indexed keywords

CANCER GROWTH FACTOR; CPG OLIGODEOXYNUCLEOTIDE; FIBRONECTIN; GAMMA INTERFERON; PLACEBO; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOWN-REGULATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUNG NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT;

EID: 81355147749     PISSN: 17762596     EISSN: 1776260X     Source Type: Journal    
DOI: 10.1007/s11523-011-0182-9     Document Type: Article

References (19)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-1164
2. Rudge G, Gleeson PA, van Driel IR (2006) Control of immune responses by immunoregulatory T cells. Arch Immunol Ther Exp (Warsz) 54:381-391 (Pubitemid 44968891)
3. Field EH, Matesic D, Rigby S, Fehr T, Rouse T, Gao Q (2001) CD4+CD25+ regulatory cells in acquired MHC tolerance. Immunol Rev 182:99-112 (Pubitemid 33070211)
4. Somasundaram R, Jacob L, Swoboda R, Caputo L, Song H, Basak S et al (2002) In-ibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta. Cancer Res 62:5267-5272 (Pubitemid 35024601)
5. Gajewski TF, Meng Y, Harlin H (2006) Immune suppression in the tumor microenvironment. J Immunother 29:233-240 (Pubitemid 44297291)
6. Sfondrini L, Besusso D, Bronte V, Macino B, Rossini A, Colombo MP, Ménard S, Balsari A (2004) CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory response. Cancer Immunol Immunother 53:697-704 (Pubitemid 38962063)
7. Smyth MJ, Teng MW, Swann J, Kyparissoudis K, Godfrey DI, Hayakawa Y (2006) CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 176:1582-1587 (Pubitemid 43134302)
8. Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5:263-274 (Pubitemid 40488632)
9. Shevach EM, DiPaolo RA, Andersson J, Zhao DM, Stephens GL, Thornton AM (2006) The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev 212:60-73 (Pubitemid 44116700)
10. Enarsson K, Johnsson E, Lindholm C, Lundgren A, Pan- Hammarström Q, Strömberg E et al (2006) Differential mechanisms for T lymphocyte recruitment in normal and neoplastic human gastric mucosa. Clin Immunol 118:24-34 (Pubitemid 43012043)
11. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942-949 (Pubitemid 39273735)
12. Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B (2003) Increase of regulatory T cells in the peripheral blood of cancer patients [J]. Clin Cancer Res 9 (2):606-612 (Pubitemid 36182591)
13. Read S, Malmström V, Powrie F (2000) Cytotoxic T lymphocyteassociated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192(2):295-302 (Pubitemid 30470312)
14. Nakamura K, Kitani A, Strober W (2001) Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194:629-644 (Pubitemid 32844773)
15. Yu P, Lee Y, LiuW, Krausz T, Chong A, Schreiber H, You Z, Kaynor C, Wang X, Fu YX (2005) Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 201:779-791 (Pubitemid 40395122)
16. Seo N, Hayakawa S, Takigawa M, Tokura Y (2001) Interleukin- 10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity. Immunology 103:449-457 (Pubitemid 32744391)
17. Chen ZM, O'Shaughnessy MJ, Gramaglia I, Panoskaltsis-Mortari A, Murphy WJ, Narula S, Roncarolo MG, Blazar BR (2003) IL- 10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function. Blood 101:5076-5083 (Pubitemid 36857776)
18. Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M, Wader T, Tluk S, Liu M, Davis HL, Krieg AM (2004) Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol 34:251-262 (Pubitemid 38111541)
19. Law JP, Hirschkorn DF, Owen RE, Biswas HH, Norris PJ, Lanteri MC (2009) The importance of Foxp3 antibody and fixation/ permeabilization buffer combinations in identifying CD4+CD25+ Foxp3+ regulatory Tcells. Cytom A 75(12):1040-1050